FI943921A0 - Bestaemning av fri och komplexbunden trypsinogen-2 - Google Patents

Bestaemning av fri och komplexbunden trypsinogen-2

Info

Publication number
FI943921A0
FI943921A0 FI943921A FI943921A FI943921A0 FI 943921 A0 FI943921 A0 FI 943921A0 FI 943921 A FI943921 A FI 943921A FI 943921 A FI943921 A FI 943921A FI 943921 A0 FI943921 A0 FI 943921A0
Authority
FI
Finland
Prior art keywords
trypsinogen
pct
trypsin
free
complex
Prior art date
Application number
FI943921A
Other languages
English (en)
Other versions
FI100557B (fi
FI943921A (fi
Inventor
Ulf-Haokan Stenman
Johan Hedstroem
Original Assignee
Stenman Ulf Haokan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stenman Ulf Haokan filed Critical Stenman Ulf Haokan
Publication of FI943921A0 publication Critical patent/FI943921A0/fi
Priority to FI943921A priority Critical patent/FI100557B/fi
Priority to DK95929116T priority patent/DK0777860T3/da
Priority to EP95929116A priority patent/EP0777860B1/en
Priority to PCT/FI1995/000453 priority patent/WO1996007104A1/en
Priority to DE69524107T priority patent/DE69524107T2/de
Priority to AT95929116T priority patent/ATE209359T1/de
Priority to JP50851296A priority patent/JP3522764B2/ja
Priority to ES95929116T priority patent/ES2168378T3/es
Priority to US08/793,534 priority patent/US5976809A/en
Publication of FI943921A publication Critical patent/FI943921A/fi
Application granted granted Critical
Publication of FI100557B publication Critical patent/FI100557B/fi

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
FI943921A 1994-08-26 1994-08-26 Vapaan trypsinogeeni-2:n määritys FI100557B (fi)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FI943921A FI100557B (fi) 1994-08-26 1994-08-26 Vapaan trypsinogeeni-2:n määritys
DE69524107T DE69524107T2 (de) 1994-08-26 1995-08-24 Bestimmung von freiem und komplexiertem trypsinogen-2
EP95929116A EP0777860B1 (en) 1994-08-26 1995-08-24 Assay of free and complexed trypsinogen-2
PCT/FI1995/000453 WO1996007104A1 (en) 1994-08-26 1995-08-24 Assay of free and complexed trypsinogen-2
DK95929116T DK0777860T3 (da) 1994-08-26 1995-08-24 Analyse af frit og kompleksbundet trypsinogen-2
AT95929116T ATE209359T1 (de) 1994-08-26 1995-08-24 Bestimmung von freiem und komplexiertem trypsinogen-2
JP50851296A JP3522764B2 (ja) 1994-08-26 1995-08-24 遊離及び複合化トリプシノーゲン−2のアッセイ
ES95929116T ES2168378T3 (es) 1994-08-26 1995-08-24 Determinacion de tripsinogeno-2 libre y en forma de complejo.
US08/793,534 US5976809A (en) 1994-08-26 1995-08-24 Assay of free and complexed trypsinogen-2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI943921A FI100557B (fi) 1994-08-26 1994-08-26 Vapaan trypsinogeeni-2:n määritys

Publications (3)

Publication Number Publication Date
FI943921A0 true FI943921A0 (fi) 1994-08-26
FI943921A FI943921A (fi) 1996-02-27
FI100557B FI100557B (fi) 1997-12-31

Family

ID=8541252

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943921A FI100557B (fi) 1994-08-26 1994-08-26 Vapaan trypsinogeeni-2:n määritys

Country Status (9)

Country Link
US (1) US5976809A (fi)
EP (1) EP0777860B1 (fi)
JP (1) JP3522764B2 (fi)
AT (1) ATE209359T1 (fi)
DE (1) DE69524107T2 (fi)
DK (1) DK0777860T3 (fi)
ES (1) ES2168378T3 (fi)
FI (1) FI100557B (fi)
WO (1) WO1996007104A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020511517A (ja) * 2017-03-22 2020-04-16 ザ チルドレンズ メディカル センター コーポレーション Prss2阻害
US11466080B2 (en) 2017-03-22 2022-10-11 Children's Medical Center Corporation Methods of treating cancer using anti-LRP1 polyclonal antibodies
JP7355140B2 (ja) * 2022-02-28 2023-10-03 住友ベークライト株式会社 セリンプロテアーゼの検出用または測定用試薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3016575A1 (de) * 1980-04-30 1981-11-05 Merck Patent Gmbh, 6100 Darmstadt Verfahren zur immunologischen bestimmung von enzymen, mittel zur durchfuehrung des verfahrens und seine verwandung
CA1176560A (en) * 1980-09-30 1984-10-23 Peter C. Harpel Process for determining inhibitor-enzyme complexes and composition for use therein

Also Published As

Publication number Publication date
DK0777860T3 (da) 2002-05-21
ES2168378T3 (es) 2002-06-16
WO1996007104A1 (en) 1996-03-07
EP0777860B1 (en) 2001-11-21
DE69524107T2 (de) 2002-06-06
JPH10504902A (ja) 1998-05-12
ATE209359T1 (de) 2001-12-15
US5976809A (en) 1999-11-02
FI100557B (fi) 1997-12-31
DE69524107D1 (de) 2002-01-03
JP3522764B2 (ja) 2004-04-26
FI943921A (fi) 1996-02-27
EP0777860A1 (en) 1997-06-11

Similar Documents

Publication Publication Date Title
AU2002229970B2 (en) Urine assay for ovarian reserve
DK0540573T4 (da) Assay for frit- og kompleksbundet prostataspecifikt antigen (PSA)
DK0483194T3 (da) IgG3-antistoffer med forkortet hængselsregion og en komplementaktiveringstest
ATE326484T1 (de) Monoklonaler antikörper gegen flt4-rezeptor- tyrosinkinase und dessen verwendung zur diagnose und therapie
AU2002229970A1 (en) Urine assay for ovarian reserve
KR890015714A (ko) 폐암의 조기 검출 방법
ES2070488T5 (es) Procedimiento para la diagnosis de enfermedades tumorales.
DE3800048A1 (de) Verfahren zur bestimmung eines antikoerpers in menschlichen koerperfluessigkeiten
DE3780480D1 (de) Test fuer menschlichen brustkrebs.
FI943921A0 (fi) Bestaemning av fri och komplexbunden trypsinogen-2
DE69530432T2 (de) Monoklonaler Antikörper gegen den Thrombin-Antithrombin Komplex-III und dessen Verwendung in immunoassays
NO973823L (no) Påvisning av antistoffproduksjon
DE69523492D1 (de) Immunoassay-Reagenzien, Testsätze und Verfahren
KR870002453A (ko) 프로좀 단백질에 대한 단일항체의 제조방법 및 그를 이용한 프로좀과 관련된 현상의 검출 및 질병의 진단법
ATE286596T1 (de) Chemische modifikation von antikörpern und antigenen
KR950009257A (ko) 골다공증 진단제
Jelaković et al. Antibodies to Tamm–Horsfall protein in endemic nephropathy
KR890702037A (ko) 간장암 질환의 진단법

Legal Events

Date Code Title Description
MM Patent lapsed